SINGAPORE (Apr 26): Hyphens Pharma International, the specialty pharmaceutical and consumer healthcare group which also owns the Ocean Health brand of supplements, has lodged a preliminary offer document with Singapore Exchange (SGX) to list on its Catalist Board in 2018.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

Subscribe